Spectrum Healthcare Partners Taps Proscia To Democratize Cancer Diagnosis
Summary
Digital pathology, which shifts the 150-year-old standard of care from microscope to whole slide image, is democratizing diagnostic services for diseases like cancer at a time when an intensifying workforce shortage is putting added pressure on laboratories to keep pace with rising biopsy volume. As SHCP serves patients across various healthcare systems, it recognized an opportunity to pioneer the use of digital pathology in its region to expand the reach of its subspecialist experts and deliver timely results. “We believe that all patients, regardless of geography, deserve access to high-quality care,” said Bilal R. Ahmad, MD, MBA, FCAP, Managing Director, Pathology Division at Spectrum Healthcare Partners. “We are excited to welcome Spectrum Healthcare Partners to the growing roster of hospital systems and diagnostic laboratories adopting Concentriq Dx,” said David West, Proscia’s CEO. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care.